Synapsica Healthcare creates India’s first integrated platform using AI to automate clinical and back office tasks in radiology
New Delhi-based startup Synapsica Healthcare recently announced $ 4.2 million in Series A funding backed by VC funds IvyCap Ventures and Endiya Partners. The Silicon Valley-based incubator Y Combinator and other angel investors also took part in the financing round.
Synapsica aims to improve the quality of radiology reports while making it easier for clinicians to create them. The new capital would be used to grow overseas and further expand the AI capabilities that radiologists and spine specialists can use to generate patient reports quickly or even in real-time at the table.
Synapsica’s platform – Radiolens – enables radiologists and clinicians to compile reports with illustrations and objective evidence of disease, creating transparency and therefore better patient care for the community. Radiolens hosts several artificial intelligence-based algorithms that help radiologists describe the exact location and extent of spinal pathologies.
Given the increasing incidence of chronic back and neck pain among the elderly and working professionals, the reports generated on the Synapsica platform help both patients and clinicians understand the patient’s condition and create a tailored treatment plan.
“We are obsessed with the experience of the radiologists on our platform and we focus our research and technical development on creating the best possible environment for clinical diagnosis. This means that all day-to-day tasks – key clicks, measurements, repetitive diagnoses – are eliminated and time is given back to focus on the patient, ”says Meenakshi, CEO of Synapsica Healthcare.
Vikram Gupta, Founder and Managing Partner of IvyCap Ventures Advisors, said, “There is an ongoing need to make high quality diagnostic assessments available to everyone. Synapsica helps with its AI tools in the rapid creation of patient reports. Our investment in the company should support them in their expansion and growth. “